Radiant Biotherapeutics
PrivateLast Round
Series A
Sep 11, 2024
Est. Valuation
$65M
Total Funding Raised
$45.17M
Company Overview
Radiant Biotherapeutics is a biopharmaceutical company that develops a modular multi-valent and multi-specific platform to create potent biologics aimed at treating challenging diseases like cancer, autoimmune disorders, and infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radiant Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Radiant Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 11, 2024 | ||||
| Grant | Dec 20, 2023 | ||||
| Seed | Apr 25, 2023 |
Key People
Founding team and executive leadership
Radiant Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Series A, Seed |
| Business Development Bank of Canada (BDC Capital) | Series A |
| The Bill & Melinda Gates Foundation Trust | Grant, Series A |
| Aberdeen | Series A |
| TIAP | Series A, Seed |
| FACIT | Series A, Seed |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2025
New data from lead oncology program to be presented at SITC 2025.
- Oct 3, 2025
Will attend and present at the SITC 2025 Annual Meeting.
Radiant Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Radiant Biotherapeutics's valuation, stock price, and market status.
